Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle

Circulation

Volumn 97, Issue 7, 1998, Pages 651-660

  Kaprielian, Raffi R ^a   Gunning, Mark ^a   Dupont, Emmanuel ^a   Sheppard, Mary N ^b   Rothery, Stephen M ^a   Underwood, Richard ^b   Pennell, Dudley J ^b   Fox, Kim ^b   Pepper, John ^b   Poole Wilson, Philip A ^a   Severs, Nicholas J ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Hibernation; Junctions, gap; Myocardial contraction

Indexed keywords

CONNEXIN 43; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; GAP JUNCTION; HEART INFARCTION; HEART VENTRICLE FAILURE; HIBERNATION; HUMAN; HUMAN TISSUE; LASER MICROSCOPY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STUNNED HEART MUSCLE;

EID: 0032562150     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.7.651     Document Type: Article

References (47)

1. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation. 1985;72(suppl V):V-123-V-135.
2. Rahimtoola SH. The hibernating myocardium. Am Heart J. 1989;117:211-221.
3. Borgers M, Thone F, Wouters L, Ausma J, Shivalkar B, Flameng W. Structural correlates of regional myocardial dysfunction in patients with critical coronary artery stenosis: chronic hibermation? Cardiovasc Pathol. 1993;2:237-245.
4. Maes A, Flameng W, Nuyts J, Borgers M, Shivalkar B, Ausma J, Bormans G, Schiepers C, DeRoo M, Mortelmans L. Histological alterations in chronically hypoperfused myocardium: correlation with PET findings. Circulation. 1994;90:735-745.
5. Nienaber CA, Brunken RC, Sherman CT, Yeatman CT, Gambhir SS, Krivokapich J, Demer LL, Ratib O, Child JS, Phelps ME, Schelbert HR. Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty. J Am Coll Cardiol. 1991;18:996-978.
6. Kaprielian RR, Sheppard M, Gunning M, Underwood R, Pennell DJ, Fox K, Rothery S, Pepper J, Poole-Wilson PA, Severs N. Myocardial structure correlates with thallium uptake but not with recovery of ventricular function in patients with hibernating myocardium. Eur Heart J. 1996;17(suppl):15. Abstract.
7. Schaper J, Froede R, Hein St, Buck A, Hashizume H, Speiser B, Friedl A, Bleese N. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation. 1991;83:504-514.
8. Sharp WW, Terracio L, Borg TK, Samarel AM. Contractile activity modulates actin synthesis and turnover in cultured neonatal rat heart cells. Circ Res. 1993;73:172-183.
9. DiCarli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken RC, Czernin J, Rokhsar S, Stevenson LW, Laks H, Hawkins R, Schelbert HR, Phelps ME, Maddahi J. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol. 1994;73:527-533.
10. Eitzman D, Al-Aouar Z, Kantar HL, Vom Dahl J, kirsh M, Deeb GM, Schwaiger M. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol. 1992;20:559-565.
11. Quan W, Rudy Y. Unidirectional block and recntry of cardiac excitation: a model study. Circ Res. 1990;66:367-382.
12. Tomaselli GF, Beuckelmann DJ, Calkins HG, Berger RD, Kessler PD, Lawrence JH, Kass D, Feldman AM, Marban E. Sudden death in heart failure: the role of abnormal repolarization. Circulation. 1994;90:2534-2539.
13. Ben-David J, Zipes DP, Ayers GM, Pride HP. Canine left ventricular hypertrophy predisposes to ventricular tachycardia induction by phase 2 early afterdepolarizations after administration of BAY K 8644. J Am Coll Cardiol. 1992;20:1576-1584.
14. Kuo CS, Munakata K, Reddy CP, Surawitz B. Characteristics and possible mechanisms of ventricular arrhythmias dependent on the dispersion of action potential duration. Circulation. 1983;67:1356-1367.
15. Lesh MD, Pring M, Spear JF. Cellular uncoupling can unmask dispersion of action potential duration in ventricular myocardium. Circ Res. 1989;65:1426-1440.
16. Severs NJ, Dupont E, Kaprielian RR, Yeh H-I, Rothery S. Gap junctions and connexins in the cardiovascular system. In: Yacoub MH, Carpentier A, Pepper J, Fabiani J-N, eds. Annual of Cardiac Surgery 1996. 9th ed. London, UK: Current Science; 1996;31-44.
17. Severs NJ, Cardiac muscle cell interaction: from microanatomy to the molecular make-up of the gap junction. Histol Histopathol. 1995;10:481-501.
18. Gros DB, Jongsma HJ. Connexins in mammalian heart function. Bioessays 1996;18:719-730.
19. Saffitz JE, Corr PB, Sobel BE. Arrhythmogenesis and ventricular dysfunction after myocardial infarction: is anomalous cellular coupling the elusive link? Circulation. 1993;87:1742-1745.
20. Smith JH, Green CR, Peters NS, Rothery S, Severs NJ. Altered patterns of gap junction distribution in ischemic heart disease: an immunohistochemical study of human myocardium using laser scanning confocal microscopy. Am J Pathol. 1991;139:801-821.
21. Peters NS, Coromilas J, Severs NJ, Wit AL. Disturbed connexin43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation. 1997;95:988-996.
22. Peters NS, Green CR, Poole-Wilson PA, Severs NJ. Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation. 1993;88:864-875.
23. Pennel DJ, Underwood R, Manzara CC, Ell PJ, Swanton RH, Walker JM, Longmore DB. Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol. 1992;70:34-40.
24. Toshimori H, Toshimori K, Oura C, Matsuo H. Immunohistochemistry and immunocytochemistry of natriuretic polypeptide in porcine heart. Histochemistry. 1987;86:595-601.
25. Cattoretti G, Pileri S, Parravicini C, Becker MHG, Poggi S, Bifulco C, Key G, D'Amato L, Saattini E, Feudale E, Reynolds F, Gerdes J, Rilke F. Antigen unmasking on formalin-fixed paraffin-embedded tissue sections. J Pathol. 1993;171:83-98.
26. Sepp R, Severs NJ, Gourdie RG. Altered patterns of cardiac intercellular junction distribution in hypertrophic cardiomyopathy. Heart. 1996;76:412-417.
27. Harlow E, D Lane. Antibodies: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Press; 1988.
28. Green CR, Peters NS, Gourdie RG, Rothery S, Severs NJ. Validation of immunohistochemical quantification in confocal scanning laser microscopy: a comparative assessment of gap junction size with confocal and ultrastructural techniques. J Histochem Cytochem. 1993;41:1339-1349.
29. Luke RA, Saffitz JE, Remodeling of ventricular conduction pathways in healed canine infarct border zones. J Clin Invest. 1991;87:1594-1602.
30. Campos De Carvalho AC, Tanowitz HB, Wittner M, Dermietzel R, Roy C, Hertzberg EL, Spray DC. Gap junction distribution is altered between cardiac myocytes infected with Trypanosoma cruzi. Circ Res. 1992;70:733-742.
31. Barr L, Dewey MM, Berger W. Propagation of action potentials and the structure of the nexus in cardiac muscle. J Gen Physiol. 1965;48:797-823.
32. Spray DC, Burt JM. Structure-activity relations of the cardiac gap junction channel. Am J Physiol. 1990;258:C195-C1205.
33. Saffitz JE, Davis LM, Darrow BJ, Kanter HL, Laing JG, Beyer EC. The molecular basis of anisotrophy: role of gap junctions. J Cardiovasc Electrophysiol. 1995;6:498-510.
34. Rook MB, deJonge B, Jongsma HJ, Masson-Pever MA. Gap junction formation and functional interaction between neonatal rat cardiocytes in culture: a correlative physiological and ultrastructural study. J Membr Biol. 1990;118:179-192.
35. Darrow BJ, Fast VG, Kléber AG, Beyer EC, Saffitz JE. Functional and structural assessment of intercellular communication: increased conduction velocity and enhanced connexin expression in dibutyryl cAMP-treated cultured cardiac myocytes. Circ Res. 1996;79:174-183.
36. Guerrero PA, Schuessler RB, Davis LM, Beyer EC, Johnson CM, Yamada KA, Saffitz JE. Slow ventricular conduction in mice heterogeneous for a connexin43 null mutation. J Clin Invest. 1997;99:1991-1998.
37. Gellens ME, George AL, Chen L, Chahine M, Horn R, Barchi RL, Kallen RG. Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel. Proc Natl Acad Sci U S A. 1992;89:554-558.
38. Haimovich B, Bonilla E, Casades J, Barchi R. Immunocytochemical localisation of the mammalian voltage dependent sodium channel using polyclonal antibodies against the purified protein. J Neurosci. 1984;4:2259-2268.
39. Cohen SA. Immunocytochemical localization of rH1 sodium channel in adult rat heart and ventricular presence in terminal intercalated disks. Circulation. 1994;94:3083-3086.
40. Fujimoto T, Peter R, Hamamoto H, Mandel WJ. Electrophysiological observation during the spontaneous mutation of ischemia induced ventricular fibrallation. Am Heart J. 1983;105:189-197.
41. Antzelevitch C, Sicouri S, Litovsky SH, Lukas A, Krishnan SC, Di Diego JM, Ginatane GA, Liu D. Heterogeneity within the ventricular wall: electrophysiology and pharmacology of epicardial, endocardial, and M cells. Circ Res. 1991;69:1427-1449.
42. Nahauer M, Beuckelman DJ. Regional differences in current density and properties of the transient outward current in human ventricular myocytes. Circulation. 1993;88(suppl 1):1-89.
43. Arnos GJ, Wettwer E, Posival H, Ravens U. Transient outward current (Ito) in ventricular myocytes in subepicardial and subendocardial regions of human hearts. Circulation. 1993;88(suppl 1):1-34. Abstract.
44. - currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res. 1993;73:379-395.
45. Lue W-M, Boyden PA. Abnormal electrical properties of myocytes from chronically infarcted canine heart: alterations in V and the transient outward current. Circulation. 1992;85:1175-1188.
46. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during perfusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol. 1994;23:617-626.
47. Arnese M, Cornell JH, Salustri A, Maat APWM, Elhendy A, Reijs AEM, Ten Cate FT, Keane D, Baik AHMM, Roelandt JRTC, Fioretti PM. Prediction of improvement of regional left ventricular function after surgical revascularization: a comparison of low-dose dobutamine echocardiography with T1 single-photon emission tomography. Circulation. 1995;91:2748-2752.